The Centers for Disease Control and Prevention (CDC) awarded a cooperative agreement to the Council of Medical Specialty Societies (CMSS) to improve vaccination among high-risk adults. This five-year quality improvement initiative is focused on increasing immunization rates for high-risk adults with chronic medical conditions.

CMSS has partnered with seven specialty societies to implement targeted immunization and quality improvement strategies and activities which will support increased vaccination of high-risk patients served by their members.

The American Society of Clinical Oncology, Inc. (ASCO®) is committed to the principle that knowledge conquers cancer. Together with the Association for Clinical Oncology, ASCO represents nearly 45,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of high quality, equitable patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. Conquer Cancer, the ASCO Foundation, supports ASCO by funding groundbreaking research and education across cancer’s full continuum. To learn more about our involvement within the Specialty Societies Advancing Adult Immunizations project, please click here. 

The Specialty Societies Advancing Adult Immunization (SSAAI) program is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award to the Council of Medical Specialty Societies (CMSS) totaling $42,175,407 with 100 percent funded by CDC/HHS. The contents are those of the authors and do not necessarily represent the official views of nor endorsement, by CDC/HHS or the U.S. Government.